Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy

• Main Authors: Aurpibul L., Puthanakit T., Sirisanthana T., Sirisanthana V.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-77951814475&partnerID=40&md5=2f0ea52adec1111a9724c5f9c093fa12; http://www.ncbi.nlm.nih.gov/pubmed/20377409; http://cmuir.cmu.ac.th/handle/6653943832/2581
• Institution: Chiang Mai University

Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%...